Abstract:Jerzy P Szaflarski, 1 Magdalena Szaflarski 2 1 Department of Neurology, University of Alabama at Birmingham (UAB), Heersink School of Medicine, Birmingham, AL, USA; 2 Department of Sociology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA Correspondence: Jerzy P Szaflarski, Department of Neurology, University of Alabama at Birmingham (UAB) Heersink School of Medicine, 312 Civitan International Research Center1719 6th Avenue South, Birmingham, AL, 35294-0021, USA, Email Purpose: Basic science data indicate potential neuroprotective effects of cannabinoids in traumatic brain injury (TBI). We aimed to evaluate the effects of pre-TBI recreational cannabis use on TBI outcomes. Patients and Methods: We used i2b2 (a scalable informatics framework; www.i2b2.org ) to identify all patients presenting with acute TBI between 1/1/2014 and 12/31/2016, then conducted a double-abstraction medical chart review to compile basic demographic, urine drug screen (UDS), Glasgow Coma Scale (GCS), and available outcomes data (mortality, modified Rankin Scale (mRS), duration of stay, disposition (home, skilled nursing facility, inpatient rehabilitation, other)) at discharge and at specific time points thereafter. We conducted multivariable nested ordinal and logistic regression analyses to estimate associations between cannabis use, other UDS results, demographic factors, and selected outcomes. Results: i2b2 identified 6396 patients who acutely presented to our emergency room with TBI. Of those, 3729 received UDS, with 22.2% of them testing positive for cannabis. Mortality was similar in patients who tested positive vs negative for cannabis (3.9% vs 4.8%; p = 0.3) despite more severe GCS on admission in the cannabis positive group (p = 0.045). Several discharge outcome measures favored the cannabis positive group who had a higher rate of discharge home vs other care settings (p < 0.001), lower discharge mRS (p < 0.001), and shorter duration of hospital stay (p < 0.001) than the UDS negative group. Multivariable analyses confirmed mostly independent associations between positive cannabis screen and these post-TBI short- and long-term outcomes. Conclusion: This study adds evidence about the potentially neuroprotective effects of recreational cannabis for short- and long-term post-TBI outcomes. These results need to be confirmed via prospective data collections. Keywords: cannabis, traumatic brain injury, Glasgow Coma Scale, GCS, outcomes, modified Rankin Scale, mRS Every year, traumatic brain injury (TBI) affects over 2 million individuals in the US with a global estimate of 69 million new cases. 1,2 Among various negative long-term sequelae, deficits in information processing, attention, working memory, and executive functioning occur in up to 65% of TBI survivors. 3 These deficits interfere with independence and reintegration into society, affect family functioning and well-being, and produce significant caregiver strain. 4,5 However, despite many past studies, there is no specific treatment to ameliorate the emergence of post-TBI deficits. 6,7 Thus, it is important to develop investigations into the factors that shape post-TBI outcomes. In response to TBI, brain undergoes many primary and secondary structural, metabolic, and vascular changes. 8–10 These changes include increases in pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α 11–14 and changes in molecular pathways for chronic inflammatory transmitters such as vascular cell adhesion molecule-1 (VCAM-1) and cannabinoid receptor-2 (CB 2 R), a marker of neuroinflammation predominantly expressed in activated microglia. 15–17 There is evidence that the neuroinflammatory cascade is involved in producing some of the deficits seen after TBI 18–23 and that blocking neuroinflammation during the acute phase of TBI may be neuroprotective. 24,25 As part of the neuro-metabolic response to TBI, the endocannabinoid system (ECS) offers a potential route for modifying neuroinflammation via its interactions with neurons and glia. 26,27 The interaction between phytocannabinoids, terpenes, and flavonoids and the ECS and other homeostatic systems has been studied in a substantial detail. 28 This includes not only anti-inflammatory and neuroprotective investigations but also research into the effects of phyto- and endocannabinoids on epileptogenesis and cognition. 29–31 Thus, basic and clinical science work has made important strides toward understanding the divergent roles of the ECS and the dynamics of its receptors (CB 1 R/CB 2 R) and neurotransmitter -Abstract Truncated-

Purinergic astrocyte signaling driven by TNF-α after cannabidiol administration restores normal synaptic remodeling following traumatic brain injury

CTGF Triggers Rat Astrocyte Activation and Astrocyte-Mediated Inflammatory Response in Culture Conditions

Cannabidiol alleviates neurological deficits after traumatic brain injury by improving intracranial lymphatic drainage

Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats

Neuroprotective Effects of Resatorvid Against Traumatic Brain Injury in Rat: Involvement of Neuronal Autophagy and TLR4 Signaling Pathway

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury

Enhancing endocannabinoid signalling in astrocytes promotes recovery from traumatic brain injury

Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With Traumatic Brain Injury

TAK-242, a Toll-Like Receptor 4 Antagonist, Against Brain Injury by Alleviates Autophagy and Inflammation in Rats

Single-cell RNA-sequencing analysis reveals enhanced non-canonical neurotrophic factor signaling in the subacute phase of traumatic brain injury

Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injury

Tetrahydrocurcumin Protects Against GSK3β/PTEN/PI3K/Akt-Mediated Neuroinflammatory Responses and Microglial Polarization Following Traumatic Brain Injury

PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury

Traumatic Brain Injury Outcomes After Recreational Cannabis Use

TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury

Neuroprotective effects of resveratrol against traumatic brain injury in rats: Involvement of synaptic proteins and neuronal autophagy

Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism

Dual Roles of Astrocytes in Plasticity and Reconstruction after Traumatic Brain Injury

Inhibition of PDE10A-Rescued TBI-Induced Neuroinflammation and Apoptosis Through the Camp/pka/nlrp3 Pathway

Molecular Mechanisms and Signaling Pathways of Reactive Astrocytes Responding to Traumatic Brain Injury

A Novel Cognitive Impairment Mechanism That Astrocytic P-Connexin 43 Promotes Neuronic Autophagy Via Activation of P2X7R and Down-Regulation of GLT-1 Expression in the Hippocampus Following Traumatic Brain Injury in Rats.